Kymera Therapeutics Non-Current Deferred Revenue (Quarterly) Analysis

Kymera Therapeutics, Inc. (KYMR)

74.77 -0.21 (-0.28%) USD | NASDAQ | Jan 09, 16:00

74.75 -0.02 (-0.03%) After-Hours: 06:12

View Non-Current Deferred Revenue (Quarterly) for KYMR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
Gilead Sciences, Inc.	--
Cytokinetics, Inc.	--
TG Therapeutics, Inc.	Upgrade
Protagonist Therapeutics, Inc.	--